Our partners and sponsors rely on our legacy, expert staff, and state-of-the-art facilities to conduct safe, ethical, and diverse clinical trials. At CRP, we're committed to exceeding expectations every step of the way.
Hundreds of programs delivered safely, ethically, and on protocol since 1996.
Higher retention, lower dropout, and fewer protocol deviations across studies.
Board-certified investigators with combined decades of GCP-trained experience.
Demographics aligned with sponsor diversity action plans and FDA guidance.
Integrated eSource, eCRF, and EDC for cleaner data and faster monitoring.
Pre-screening pipelines that accelerate first-patient-in from greenlight.
Trials supported across 20+ FDA-approved therapies — see below.
Greenlight to first screen in <7 days; regulatory package complete in 10.
Figures based on data from our last 10 trials and metrics pulled from NIH guidelines
AbbVie
Merck
Amgen
Novartis
Roche
Biogen
Eli Lilly
Pfizer
Novo Nordisk
Bayer
Sanofi
Bristol Myers Squibb
Viatris
Janssen
GSK
Daiichi Sankyo
Teva
Takeda
AstraZeneca
Boehringer IngelheimNot Exhaustive
Deep program experience across four major areas, with on-site infrastructure for each.
A selection of approved therapies from trials our team has supported. Not Exhaustive.
Two state-of-the-art sites in PA and NJ with on-site CRIO and BigQuery analytics, FibroScan, ultrasound, full IP storage with 24/7 monitoring, dedicated sponsor and monitor workspace, and a sample processing lab.
"CRP's commitment and professionalism is inspiring."IQVIA & Daiichi Sankyo
"Working with CRP's dedicated team has always been a great pleasure."Bayer